Raymond James Maintains Outperform on Insulet, Lowers Price Target to $299
Portfolio Pulse from richadhand@benzinga.com
Raymond James analyst Jayson Bedford has maintained an Outperform rating on Insulet (NASDAQ:PODD), but lowered the price target from $350 to $299.
August 09, 2023 | 11:50 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Insulet's price target has been lowered by Raymond James from $350 to $299, though the Outperform rating is maintained.
The lowering of the price target by Raymond James could potentially create a negative sentiment among investors, which might put downward pressure on the stock price. However, the maintenance of the Outperform rating indicates that the analyst still sees potential upside for the stock, which could counterbalance the negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100